Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...

Medical has completed the integration and design enhancements of the Apex 6 Generator into a fully integrated transvascular ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Africa accounts for only 3% of all medicine production globally, and more than 90% of drugs and 99% of vaccines consumed are imported.1 The continent has not been well positioned to address these gaps ...

Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods.

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...